偏头痛治疗的新希望

Fresh insights into the causes of migraines are prompting us to take a closer look at a drug target that was sidelined 25 years ago, discovers Caroline Williams WE COULD be on the cusp of a new wave of migraine therapies. Revisiting a neurological pathway that has long been dismissed for treating the painful condition has yielded promising results. By understanding the various mechanisms behind migraine, which affects more than 1 billion people worldwide, we could provide relief for the 1 in 3 people with the condition who don’t respond to current treatments. Messoud Ashina at the University of Copenhagen in Denmark and his colleagues have looked at a chemical messenger, or neuropeptide, called substance P. …